Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?

被引：0
|
作者：
Valentina Ambrosini
Davide Campana
Cristina Nanni
Silvia Cambioli
Paola Tomassetti
Domenico Rubello
Stefano Fanti
机构：
[1] S. Orsola-Malpighi University Hospital,Nuclear Medicine
[2] S. Orsola-Malpighi University Hospital,Internal Medicine
[3] Ospedale S. Maria della Misericordia,Nuclear Medicine
[4] Azienda Ospedaliero Universitaria di Bologna,Nuclear Medicine, Pad 30
[5] Policlinico S. Orsola-Malpighi,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词：
Ga-DOTA-NOC; PET/CT; NET; Appropriate use;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1278 / 1283
页数：5
相关论文
共 50 条
  • [41] The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centers
    Haidar, Mohamad
    Shamseddine, Ali
    Panagiotidis, Emmanouil
    Jreige, Mario
    Mukherji, Deborah
    Assi, Rita
    Abousaid, Rayan
    Ibrahim, Toni
    Haddad, Marwan M.
    Vinjamuri, Sobhan
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (02) : 170 - 177
  • [42] Physiological uptake of 68Ga-DOTA-NOC in the head of the pancreas in patients with NET
    Castellucci, Paolo
    Fuccio, Chiara
    Allegri, Vincenzo
    Montini, Gian Carlo
    Ambrosini, Valentina
    Nanni, Cristina
    Santi, Ivan
    Celli, Monica
    Boschi, Stefano
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [43] 68Ga-DOTATATE PET/CT in the Initial Diagnosis of Patients With Clinical, Imaging, and/or Biochemical Suspicion of a Neuroendocrine Tumor
    Metser, Ur
    Ezzat, Shereen
    Singh, Simron
    Myrehaug, Sten
    Rahimi, Shiva
    Gray, Daryl
    Singnurkar, Amit
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (11) : 933 - 936
  • [44] Oncogenic osteomalacia: Can 68Ga-DOTA-NOC PET/CT pick the culprit lesion amongst multiple lesions?
    Singh, Deepa
    Gambhir, Sanjay
    Arya, Amitabh
    Ravina, Mudalsha
    Verma, Shashwat
    Barai, Sukanta
    Sankar, Gowri
    Siddegowda, Murthy
    Kumar, Narvesh
    Dubey, Veeresh
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [45] Retrospective analysis of 68Ga-DOTA- NOC PET and CT for bone metastasis detection in neuroendocrine tumours patients
    Ambrosini, Valentina
    Nanni, Cristina
    Zompatori, Maurizio
    Castellucci, Paolo
    Allegri, Vincenzo
    Rubello, Domenico
    Montini, Gian Carlo
    Grassetto, Gaia
    Franchi, Roberto
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [46] 18F-FDG PET/CT and 68Ga-DOTA-NOC PET/CT in large cell neuroendocrine carcinoma of the lung with myocardial metastasis mimicking primary heart tumor
    Stanzel, S.
    Brcic, L.
    Pernthaler, B.
    Schmid, J.
    Plhak, E.
    Aigner, R. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S848 - S848
  • [47] Should 68Ga-DOTANOC PET/CT be the first imaging investigation in patients with clinical or biochemical suspicion of neuroendocrine tumors?
    Jain, S.
    Sharma, P.
    Arora, S.
    Bal, C.
    Malhotra, A.
    Kumar, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S252 - S252
  • [48] The Role of 68Ga-DOTA-NOC PET in Evaluating Neuroendocrine Tumors: Real-World Experience from Single Lebanese Institution
    Assi, R.
    Shamseddine, A.
    Jreige, M.
    Mukherji, D.
    Abou, Said R.
    Ibrahim, T.
    Haddad, M.
    Haidar, M.
    NEUROENDOCRINOLOGY, 2016, 103 : 54 - 55
  • [49] Significance of conventional imaging & 68Ga-DOTA NOC PET/CT in neuroendocrine tumor staging & management
    Singh, Deepa
    Ravina, Mudalsha
    Kumar, Narvesh
    Jain, Suruchi
    Verma, Shashwat
    Arya, Amitabh
    Agarwal, Gaurav
    Agarwal, Amit
    Gambhir, Sanjiv
    Barai, Sukanta
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [50] 68Ga-DOTA-NOC PET/CT Detects Somatostatin Receptors Expression in von Hippel-Lindau Cerebellar Disease
    Ambrosini, Valentina
    Campana, Davide
    Allegri, Vincenzo
    Opocher, Giuseppe
    Fanti, Stefano
    CLINICAL NUCLEAR MEDICINE, 2011, 36 (01) : 64 - 65
12345